20 employees
Violett develops Luminair that disinfects pathogens in the air to breathe.
2020
$2.3M
from 3 investors over 3 rounds
Violett raised $2.3M on August 1, 2022
Investors: Pack Ventures, Alliance of Angels and Tacoma Venture Fund